Category Archives: Healthcare

Oppenheimer Gives a Hold Rating to Alnylam Pharma (ALNY)

In a report released today, Leland Gershell from Oppenheimer assigned a Hold rating to Alnylam Pharma (ALNY – Research Report), with a price target of $156.00. The company’s shares closed last Wednesday at $146.68. According to TipRanks.com, Gershell is a

The President & CEO of GeoVax Labs (NASDAQ: GOVX) is Buying Shares

Yesterday, the President & CEO of GeoVax Labs (GOVX – Research Report), David Dodd, bought shares of GOVX for $409.4K. This recent transaction increases David Dodd’s holding in the company by 100% to a total of $240.7K. In addition to

Analysts Have Conflicting Sentiments on These Healthcare Companies: Axcella Health (NASDAQ: AXLA) and Iterum Therapeutics (NASDAQ: ITRM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Axcella Health (AXLA – Research Report) and Iterum Therapeutics (ITRM – Research Report). Axcella Health (AXLA) B Riley Financial Inc. analyst Mayank Mamtani reiterated a

Needham Reaffirms Their Buy Rating on CTI BioPharma (CTIC)

Needham analyst Chad Messer reiterated a Buy rating on CTI BioPharma (CTIC – Research Report) today and set a price target of $6.00. The company’s shares closed last Wednesday at $2.09. According to TipRanks.com, Messer is a 4-star analyst with

Oppenheimer Keeps a Hold Rating on Intellia Therapeutics (NTLA)

Oppenheimer analyst Jay Olson maintained a Hold rating on Intellia Therapeutics (NTLA – Research Report) today. The company’s shares closed last Wednesday at $22.01. According to TipRanks.com, Olson ‘s ranking currently consits of 0 on a 0-5 ranking scale, with

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (NASDAQ: SLNO) and Dynatronics (NASDAQ: DYNT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Soleno Therapeutics (SLNO – Research Report) and Dynatronics (DYNT – Research Report) with bullish sentiments. Soleno Therapeutics (SLNO) In a report released